( Updated with ClickSoftware management quote.)
NEW YORK ( TheStreet) -- Several stocks trading near $5 were poised to move on above-average volume during Tuesday's session.
AspenBio Pharma (APPY) reported progress on the supplemental clinical trial for AppyScore, the first blood-based test designed to aid in the evaluation of patients suspected of having acute appendicitis. AspenBio has scheduled an interim analysis of the clinical trial data, and it has a meeting with the Food and Drug Administration scheduled for January. The 50-day average daily volume for AspenBio is 85,000 shares, according to the Nasdaq. The stock closed Monday at $1.56.
ClickSoftware (CKSW) raised revenue guidance for the fourth quarter to $17 million from the previous target range of $16 million to $16.7 million, above the Thomson Reuters consensus target of $16.5 million. "Strong bookings in the fourth quarter will contribute to the existing backlog and deferred revenues, providing us with high visibility into 2010," said CEO Dr. Moshe BenBassat. ClickSoftware now expects revenue to total $61 million for the 2009 fiscal year, compared with the average analyst target of $60.5 million. The three-month average daily volume for ClickSoftware is 437,000. Shares finished Monday's session at $6.93.Amicas (AMCS), which surged nearly 24% Monday on the company's $217-million merger agreement with private-equity firm Thomas Bravo, was downgraded by William Blair analysts to market perform from outperform Tuesday. The stock closed Monday's session at $5.47, above the $5.35-a-share price Thomas Bravo agreed to pay Amicas shareholders, although Amicas is allowed to solicit alternative proposals for 45 days beginning Dec. 24. The three-month average daily volume for Amicas is 271,000. Sterling Bancshares (SBIB) said late Monday it has terminated an agreement to buy First Banks branches in Texas as they could not gain regulatory approval before the Dec. 31 deadline. The three-month average daily volume for Sterling is 1.1 million shares. Shares ended Monday's trading session at $5.25. -- Written by Robert Holmes in Boston. Check out all of Tuesday's high-volume, under-$5 stocks at the Dollar Store Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV